BrainSightAI Joins Dassault Systèmes:Drug Discovery for Neuro-Psychiatric Disorders

Spread the love

Dassault Systèmes
 announced that the 3DEXPERIENCE Lab open innovation laboratory and accelerator program is helping BrainSightAI, an Indian startup inBrainSightAI Joins Dassault Systèmes, in its efforts to revolutionize the diagnosis and prognosis of neuro-psychiatric disorders using artificial intelligence.

·         Indian neuroscience startup BrainSightAI gains access to the 3DEXPERIENCE platform and mentoring at the 3DEXPERIENCE Lab in Pune

·         BrainSightAI is using BIOVIA applications to enable the implementation of enhanced machine-learning data pipelines

·         BrainSightAI is leveraging SIMULIA applications to create actionable 3D reports for doctors and patients, and simulate prognosis.

Pune, India  November 19, 2020 — Dassault Systèmes (Euronext Paris: #13065, DSY.PA) announced that the 3DEXPERIENCE Lab open innovation laboratory and accelerator program is helping BrainSightAI, an Indian startup in neuroscience, in its efforts to revolutionize the diagnosis and prognosis of neuro-psychiatric disorders using artificial intelligence. The BrainSightAI MRI solutions for functional and structural investigation give an unprecedented view into the patient, enabling early screening, diagnosis and modeling. It combines AI and neuroscience to enable greater precision in neurological and psychiatric investigation for accelerated patient outcomes.

As part of the 3DEXPERIENCE Lab, BrainSightAI is using BIOVIA and SIMULIA applications powered by the 3DEXPERIENCE platform to create a world-class next generation pipeline where data from clinical trials and real-world evidence from hospitals can feed into research and discovery of precision medicine. Psychiatrists can leverage simulation technology to forecast challenges and outcomes for disorders such as schizophrenia, bipolar disorder and dementia. With SIMULIA applications, the team envisages the potential to develop actionable 3D visualization reports with comprehensive insights for offline consultation. Through simulation of prognosis, doctors can easily develop a medication and therapy impact on the ailing patients. 

“Early screening, early differential diagnosis and individualized modeling are the key imperatives for transforming the methodologies of mental health treatment,” said Laina Emmanuel, CEO, BrainSightAI. “With the help of Dassault Systemes’ 3DEXPERIENCE platform, our aim is to harness the power of Artificial Intelligence and Machine Learning for enabling a holistic view of patients that can lead to better outcomes and bring about a paradigm shift in how mental health is tackled as a public health issue.”

“As the Life Sciences industry moves towards more ‘personalized healthcare’, customized simulations allow for more precise analysis and predictions of human body dynamics. The 3DEXPERIENCE platform enables Life Sciences companies to deliver unmatched patient and physician experiences by connecting data, delivering life-like, multi-scale and multi-physics models, and enabling an end-to-end virtual environment for exploration, discovery, development, testing, and commercialization,” said Frederic Vacher, Head of Innovation, Dassault Systèmes. “The 3DEXPERIENCE Lab in Pune is mentoring three promising Indian startups in the domain of Life Sciences – Lucid Implants, Inali Foundation and BrainsightAI – that aim to deliver scalable solutions that will revolutionize patient care in the years ahead.”

Dassault Systèmes’ 3DEXPERIENCE Lab provides select startups with a full technology, mentoring and networking support system to accelerate their digital product development.  At the core of this development is access to the 3DEXPERIENCE platform as well as the lab’s ecosystem of incubators, mentors, accelerators and fab labs, to capitalize on knowledge and know-how in a wide range of domains, accelerate their product launches, and develop their international footprint.  In 2018, the 3DEXPERIENCE Lab was expanded to Pune to encourage and support India’s startup community.


Social media:

Share this on Twitter: @3DEXPERIENCELab helping #startup @BrainSightAI to transform patient care and drug discovery for neuro-psychiatric disorders @3DSIndia #3DEXPERIENCE

Connect with Dassault Systèmes on Twitter Facebook LinkedIn YouTube

For more information:

Dassault Systèmes’ 3DEXPERIENCE platform, 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions:


About Dassault Systèmes

Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual experience twins of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation,BrainSightAI Joins Dassault Systèmes learning and production. Dassault Systèmes brings value to more than 270,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit

3DEXPERIENCE, the Compass icon, the 3DS logo, CATIA, BIOVIA, GEOVIA, SOLIDWORKS, 3DVIA, ENOVIA, EXALEAD, NETVIBES, MEDIDATA, CENTRIC PLM, 3DEXCITE, SIMULIA, DELMIA, and IFWE are commercial trademarks or registered trademarks of Dassault Systèmes,BrainSightAI Joins Dassault Systèmes a French “société européenne” (Versailles Commercial Register # B 322 306 440), or its subsidiaries in the United States and/or other countries.

About BrainSight.AI

BrainSight.AI founded by Laina Emmanuel and Rimjhim Agrawal creates AI-based diagnostic tools that can help in functional investigation of the brain. This can aid psychiatrists and neurologists in diagnosing mental  disorders  using  MRI  scans, and neurosurgeons in pre-surgical planning, especially for comatose and cognitively challenged patients.  The AI-powered software empowers doctors with functional reports in a matter of hours.

The tool uses AI-based  imaging  markers  to  identify  and  classify  disorders,  such  as  schizophrenia, bipolar disorder, and early forms of dementia, and simulate effects of surgery on brain functionality. BrainSight.AI is pilot testing their prototype with two hospital chains, including the largest private hospital chain in India. For more information-

Leave a Comment